by Terry Myerson, CEO | Jun 20, 2023 | News
I can’t imagine our country without the FDA continuously assessing the safety and efficacy of medical products, or our government without the CDC monitoring and guiding public health choices. And yet, we all saw during the pandemic that there is a clear opportunity...
by Terry Myerson, CEO | May 30, 2023 | News
There is a growing global consensus that “we need to regulate AI”. The most commonly cited suggestion is that we create a new global government agency to issue licenses for developing large AI models. This suggestion is coming from brilliant people thinking...
by Truveta staff | May 17, 2023 | News
We are excited to announce the expansion of the Truveta community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously announced pioneers Pfizer, Boston Scientific Corporation, and Alpine Immune Sciences. We...
by Truveta Research | May 11, 2023 | News
Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena, MD, PhD and Christopher M Worsham, MD, MPH from Harvard University, the new research...
by Truveta staff | Apr 20, 2023 | News
Truveta is a healthcare company that is passionate about improving patient care and saving lives by harnessing the transformative potential of EHR data and artificial intelligence (AI). In a recent article from Microsoft that highlighted our vision and mission, “How...
by Terry Myerson, CEO | Apr 12, 2023 | News
UPDATE: Truveta has won the 2024 South by Southwest (SXSW) Innovation Award in Artificial Intelligence for its AI-enabled health research and the Truveta Language Model (TLM). Healthcare data traditionally has been siloed, inaccessible, and too messy to be useful for...
